Urological Disorders Resource Center
Click on the subcategory below to find drug monographs for that particular area.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Patient Information Fact Sheets
Download or print easy-to-read disease leaflets for your patients.
Phosphodiesterase type 5 inhibitors up risk of biochemical recurrence after radical prostatectomy
Current smoking reduces odds of survival in prostate cancer, according to a new study.
Prostate biopsies that combine magnetic resonance imaging (MRI) technology with ultrasound appear to give men better information regarding the seriousness of their cancer.
Rockwell Medical announced that the FDA has approved Triferic (soluble ferric pyrophosphate) as an iron replacement product to maintain hemoglobin in adults with hemodialysis dependent chronic kidney disease.
The Food and Drug Administration (FDA) has approved Natpara (parathyroid hormone; NPS Pharmaceuticals) for injection as adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism.
In-house clinics can be a cost-efficient way to provide high-quality healthcare, without having to make a large investment.
Some researchers are not convinced that high blood levels of omega-3 fatty acids are associated with an increased PCa risk.
Prostate cancer is the most common male-related malignancy in the US, the second most common cause of cancer-related death among men.
Featured courses from mycme
This module reviews all topics on the NCCPA examination blueprint relating to the Reproductive, Genitourinary, ...
With acute kidney injury often encountered in the outpatient setting, primary-care providers should know the ...
Today many men are seeking information and treatment for hypogonadism, often to address issues of ...